Skip to main content

Table 4 Antithrombotic agents used in the CAA population before and after CAA diagnosis

From: Prescribing patterns of coronary artery aneurysm in Taiwan

  Before index date After index date
1 year 3 month 6 month 1 year
N (%) N (%) N (%) N (%)
Pediatric population (N = 586)
 Aspirin 182 (31.1) 479 (81.7) 482 (82.3) 486 (82.9)
 Clopidogrel 1 (0.2) 4 (0.7) 4 (0.7) 4 (0.7)
 Dipyridamole 43 (7.3) 95 (16.2) 97 (16.6) 99 (16.9)
 Warfarin 7 (1.2) 25 (4.3) 26 (4.4) 27 (4.6)
 Heparin 5 (0.9) 31 (5.3) 33 (5.6) 34 (5.8)
Adult population (N = 811)
 Aspirin 575 (70.9) 667 (82.2) 678 (83.6) 689 (85.0)
 Clopidogrel 256 (31.6) 510 (62.9) 514 (63.4) 523 (64.5)
 Dipyridamole 127 (15.7) 81 (10.0) 94 (11.6) 108 (13.3)
 Ticlopidine 32 (3.9) 26 (3.2) 31 (3.8) 36 (4.4)
 Tirofiban 22 (2.7) 28 (3.5) 28 (3.5) 29 (3.6)
 Cilostazol 20 (2.5) 26 (3.2) 29 (3.6) 41 (5.1)
 Warfarin 60 (7.4) 126 (15.5) 132 (16.3) 141 (17.4)
 Heparin 164 (20.2) 551 (67.9) 562 (69.3) 577 (71.1)
 Enoxaparin 60 (7.4) 131 (16.2) 140 (17.3) 147 (18.1)